These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17191265)

  • 1. Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients.
    Arranz B; San L; Dueñas RM; Centeno M; Ramirez N; Salavert J; Del Moral E
    Hum Psychopharmacol; 2007 Jan; 22(1):11-5. PubMed ID: 17191265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study.
    Karagianis J; Grossman L; Landry J; Reed VA; de Haan L; Maguire GA; Hoffmann VP; Milev R
    Schizophr Res; 2009 Aug; 113(1):41-8. PubMed ID: 19535229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study.
    Karagianis J; Landry J; Hoffmann VP; Grossman L; De Haan L; Maguire G; Milev R; Holt S
    Int J Clin Pract; 2010 Oct; 64(11):1520-1529. PubMed ID: 20846199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.
    Karagianis J; Hoffmann VP; Arranz B; Treuer T; Maguire GA; de Haan L; Chawla B
    Hum Psychopharmacol; 2008 Jun; 23(4):275-81. PubMed ID: 18338426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial.
    Chawla B; Luxton-Andrew H
    Hum Psychopharmacol; 2008 Apr; 23(3):211-6. PubMed ID: 18219624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss during therapy with olanzapine orally disintegrating tablets: two case reports.
    Kozumplik O; Uzun S; Jakovljević M
    Psychiatr Danub; 2009 Mar; 21(1):72-4. PubMed ID: 19270625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
    Hsu WY; Huang SS; Lee BS; Chiu NY
    J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets.
    Crocq MA; Guillon MS; Bailey PE; Provost D
    Eur Psychiatry; 2007 Oct; 22(7):453-4. PubMed ID: 17761403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine orally disintegrating tablet: a review of efficacy and compliance.
    San L; Casillas M; Ciudad A; Gilaberte I
    CNS Neurosci Ther; 2008; 14(3):203-14. PubMed ID: 18801113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predictors of substantial weight gain in bipolar patients treated with olanzapine.
    Lipkovich I; Citrome L; Perlis R; Deberdt W; Houston JP; Ahl J; Hardy T
    J Clin Psychopharmacol; 2006 Jun; 26(3):316-20. PubMed ID: 16702898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder.
    Detke HC; DelBello MP; Landry J; Hoffmann VP; Heinloth A; Dittmann RW
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):922-934. PubMed ID: 27676420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of orally disintegrating vs regular olanzapine tablets on body weight, eating behavior, glycemic and lipid indices, and gastrointestinal hormones: a randomized, open comparison in outpatients with bipolar depression.
    Bobo WV; Epstein RA; Shelton RC
    Ann Clin Psychiatry; 2011 Aug; 23(3):193-201. PubMed ID: 21808751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.
    Kinon BJ; Hill AL; Liu H; Kollack-Walker S
    Int J Neuropsychopharmacol; 2003 Jun; 6(2):97-102. PubMed ID: 12890301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight gain during treatment of bipolar I patients with olanzapine.
    Hennen J; Perlis RH; Sachs G; Tohen M; Baldessarini RJ
    J Clin Psychiatry; 2004 Dec; 65(12):1679-87. PubMed ID: 15641874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia.
    Chue P; Jones B; Taylor CC; Dickson R
    Can J Psychiatry; 2002 Oct; 47(8):771-4. PubMed ID: 12420656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally disintegrating olanzapine for the treatment of a manic patient with esophageal stricture plus chronic pharyngitis.
    Shen YC; Lee MY; Lin CC; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):541-2. PubMed ID: 17029723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study.
    Hori H; Ueda N; Yoshimura R; Yamamoto H; Wani K; Etoh Y; Haraga K; Kitahara J; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 3):741-5. PubMed ID: 19707954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine orally disintegrating tablet vs. risperidone oral solution in the treatment of acutely agitated psychotic patients.
    Hatta K; Kawabata T; Yoshida K; Hamakawa H; Wakejima T; Furuta K; Nakamura M; Hirata T; Usui C; Nakamura H; Sawa Y
    Gen Hosp Psychiatry; 2008; 30(4):367-71. PubMed ID: 18585542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.